Search research articles
Contact Us
Filters
Showing results (841-850 of 888) with videos related to
Page
of 89
Sort By:
European Heart Journal
|
August 31, 2024
Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score
Florian A Wenzl, Peizhi Wang, Mattia Arrigo, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI
Federico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
Nature Immunology
|
October 1, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Annika Nelde, Tatjana Bilich, Jonas S Heitmann, et al.
Cardiovascular Drugs and Therapy
|
July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Matteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
Fabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 24, 2012
Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion
Harri Lempiäinen, Philippe Couttet, Federico Bolognani, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome
Sergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
Nature Methods
|
December 30, 2006
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome
Michael J Taussig, Oda Stoevesandt, Carl A K Borrebaeck, et al.
Page
of 89
Search research articles
Search
Showing results (841-850 of 888) with videos related to
Sort By:
Page
of 89
European Heart Journal
|
August 31, 2024
Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes: the KID-ACS score
Florian A Wenzl, Peizhi Wang, Mattia Arrigo, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 2, 2018
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI
Federico Conrotto, Maurizio Bertaina, Sergio Raposeiras-Roubin, et al.
Nature Immunology
|
October 1, 2020
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Annika Nelde, Tatjana Bilich, Jonas S Heitmann, et al.
Cardiovascular Drugs and Therapy
|
July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries
Matteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
May 21, 2019
Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry
Ovidio De Fillippo, Martina Cortese, Fabrizio D Ascenzo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
June 30, 2018
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel
Sergio Raposeiras-Roubín, Emad Abu-Assi, Fabrizio D'Ascenzo, et al.
European Journal of Preventive Cardiology
|
March 14, 2019
Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry
Fabrizio D'Ascenzo, Maurizio Bertaina, Francesco Fioravanti, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
October 24, 2012
Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion
Harri Lempiäinen, Philippe Couttet, Federico Bolognani, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 22, 2018
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome
Sergio Raposeiras-Roubín, Berenice Caneiro Queija, Fabrizio D'Ascenzo, et al.
Nature Methods
|
December 30, 2006
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome
Michael J Taussig, Oda Stoevesandt, Carl A K Borrebaeck, et al.
Page
of 89